RVL Pharmaceuticals plc PEG Ratio

RVL Pharmaceuticals plc (RVLP) currently reports a PEG ratio of -0.05. That is below the Healthcare sector average of 11.52. Use the charts on this page to explore RVL Pharmaceuticals plc's PEG ratio history and peer comparisons.

RVL Pharmaceuticals plc's PEG ratio of -0.05 is lower than the Healthcare sector average of 11.52. That is roughly 100.4% below the sector mean. A reading lower peers can reflect different growth expectations, capital structure, or profitability — so it is worth checking the peer comparison chart before drawing conclusions.

The PEG ratio is a valuation multiple that relates RVL Pharmaceuticals plc's market price to a fundamental measure such as earnings, sales, or book value. At -0.05, RVLP can look expensive or cheap only in context — versus its own history, growth rate, and Healthcare peers. Higher multiples often price in stronger expected growth; lower ones can signal value or concern.

Start with the current PEG ratio of -0.05, then check the historical chart for trend and the peer comparison chart for relative positioning. The Healthcare average is 11.52. From there, open related valuation or income-statement pages for RVL Pharmaceuticals plc, and consider following RVLP for alerts when major investors trade the stock.

RVL Pharmaceuticals plc is classified in the Healthcare sector. On PEG ratio, it currently shows -0.05 versus a sector average near 11.52. Sector peers often share similar capital intensity and growth regimes, so relative rankings inside Healthcare are usually more informative than comparing RVLP with unrelated industries.